To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Low birth weight (LBW), defined as birth weight below 2,500 grams, continues to be a serious public health concern worldwide, particularly in low and middle-income countries. LBW is linked with a range of adverse health consequences for the infants, both short- and long-term(1, 2). Statistics Indonesia reported that LBW rates increased from 11.32% in 2019 to 12.58% in 2022(3), although the actual burden is unknown due to inconsistent prevalence estimates across numerous independent surveys in the country. This systematic review and meta-analysis sought to estimate the prevalence of LBW in Indonesia. Four electronic databases were used to search for the relevant studies (PubMed, Scopus, Web of Science, ScienceDirect) up to August 2024. Findings were reported according to PRISMA guidelines. The meta-analysis used a random-effects model with the restricted maximum likelihood (REML) estimation method. Heterogeneity was examined using the I2 statistic, with a value ≥ 50% indicating substantial heterogeneity. Twenty-six studies published between 1985 and 2023 were eligible to be included, comprising 119,556 livebirths. Meta-analysis revealed an overall pooled prevalence of LBW of 23% (95% CI: 15, 30%; I2: 99.93%), with the study setting identified as a potential source of high heterogeneity. Thus, separate analyses for population-based and hospital-based studies were performed showing LBW prevalence of 13% (95% CI: 8, 18%) and 32% (95% CI: 20, 44%), respectively. Such a difference suggests that the sampling frame and database significantly affect estimates in Indonesia, considering that those who came to the hospital were expected to be in the high-risk pregnancy group. Moreover, birth weight data were more precisely collected through measurement in a hospital survey, compared to those in a population-based survey. Regions also played an important role as each has different population characteristics and health issues that lead to different prevalence. Our study emphasises that LBW prevalence was higher than the official reported estimate in Indonesia, and that it differed between hospital and population surveys.
The true incidence of treatment-resistant schizophrenia (TRS) remains uncertain, largely because earlier studies relied on heterogeneous definitions and retrospective assessments. The Treatment Response and Resistance in Psychosis (TRRIP) consensus established standardised diagnostic criteria, but these have rarely been applied prospectively.
Aims
To estimate the incidence of TRS prospectively by using operationalised TRRIP criteria within a large community-based trial, and to examine whether baseline demographic or clinical variables predict its emergence.
Method
We applied TRRIP criteria to 1334 participants with chronic schizophrenia enrolled in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study. TRS was defined as persistent symptoms and functional impairment following two adequate antipsychotic trials, each meeting TRRIP thresholds for duration, dose and adherence. Incidence was estimated with bootstrap resampling, and logistic regression examined associations between baseline variables and TRS onset.
Results
Of 1334 participants, 782 (58.6%) met TRRIP absolute symptom thresholds at baseline; 77 (9.8%) fulfilled full criteria for TRS during follow-up. The incidence rate was 5.68 per 100 person-years (95% CI 4.51–7.02) overall and 9.20 per 100 person-years (95% CI 7.43–11.39) among above-threshold participants. Higher baseline Positive and Negative Syndrome Scale positive and negative subscale scores and greater global illness severity were associated with TRS, although predictive performance was poor.
Conclusions
This first prospective application of TRRIP criteria to a randomised trial data-set provides robust estimates of TRS incidence. Routine clinical and demographic variables have limited predictive value, supporting the need for longitudinal, biologically informed studies that use TRRIP-aligned frameworks.
Unipolar mania (UM), defined by the occurrence of manic episodes without a history of depression, is a topic of debate within the classification of affective disorders. However, its epidemiological burden remains unclear. This systematic review and meta-analysis aimed to estimate the prevalence of UM among individuals with bipolar type I disorder (BD-I) while exploring potential sources of heterogeneity.
Methods
The study protocol was registered in Open Science Framework on 27 March 2025. Embase, MEDLINE and APA PsycInfo were searched. We included observational studies reporting data on UM prevalence rates in adults with BD-I. Pooled prevalence was estimated using the Freeman–Tukey double arcsine transformation, employing a restricted maximum likelihood random-effects model. Subgroup and meta-regression analyses were implemented to explore sources of heterogeneity.
Results
We included 26 studies, encompassing 35 independent samples and 17,716 individuals with BD-I. The pooled prevalence of UM was 21.1% (95% confidence interval: 15.5–27.4%). Although potential publication bias was detected (Egger’s p = 0.010), the trim-and-fill method did not impute any missing studies. No differences were found between clinical and community-based studies (p = 0.966). However, prevalence estimates were influenced by both geographical area (p = 0.020) and study quality (p = 0.014). Rate differences across studies may also be attributable to variations in UM diagnostic definition.
Conclusions
People with UM represent a significant subset of BD-I cases worldwide, warranting greater clinical awareness. The observed rate variability emphasizes the impact of sociocultural and methodological factors on UM diagnosis. Further research is necessary to refine diagnostic criteria and evaluate optimal treatment approaches for individuals with UM.
Cystic echinococcosis (CE) is a globally endemic zoonosis of major public health and economic importance. Although numerous studies have investigated CE in Maasailand, Kenya, up-to-date epidemiological and molecular data remain limited. This study assessed the prevalence and genetic identity of Echinococcus granulosus sensu lato in livestock from Maasailand, Kenya, to evaluate ongoing transmission dynamics. A total of 1891 slaughtered livestock, comprising 667 cattle, 592 sheep and 632 goats, were examined for CE between September 2023 and April 2024. Cysts were assessed for fertility, and parasite genotypes were identified using Polymerase Chain Reaction–Restriction Fragment Length Polymorphism and sequencing of the NADH (Nicotinamide Adenine Dinucleotide) dehydrogenase subunit 1 gene. The overall CE prevalence was 28.7%, with higher rates in cattle (37.2%) and sheep (31.9%) than in goats (16.8%). CE prevalence was significantly higher in females than in males (P < 0.001). Cysts were predominantly located in the lungs (52.9%) and liver (45.6%). Sheep showed the highest cyst fertility (11.6%), followed by goats (7.6%) and cattle (6.7%). Molecular analysis identified E. granulosus sensu stricto as the predominant species (98.9%), with E. ortleppi (0.9%) and E. canadensis (G6/7) (0.1%) detected at low frequencies. Across all livestock species, CE prevalence in Maasailand was markedly higher than previously reported in the region and other endemic areas of Kenya, indicating sustained transmission. These findings highlight the need to identify drivers of transmission to guide strengthened and scaled-up prevention and control measures in this endemic region.
Prolonged grief disorder (PGD), recently classified in ICD-11 and DSM-5-TR, is characterized by persistent and functionally impairing grief lasting beyond 6–12 months. The COVID-19 pandemic was accompanied by widespread mortality, social isolation, disrupted mourning rituals, and social disconnection, raising concerns about a potentially high burden of PGD during the pandemic period. We conducted a systematic review and meta-analysis, following PRISMA guidelines and PROSPERO registration (CRD42023463720), to estimate PGD prevalence under standardized ICD-11 and DSM-5-TR diagnostic frameworks and to examine potential moderators during the COVID-19 pandemic. PubMed, EMBASE, and the Cochrane Library were searched from inception to October 2024. Eligible studies included adults who experienced bereavement during the pandemic and were assessed using validated PGD instruments (PG-13-R, ICG, BGQ). Random-effects models were applied to pool prevalence estimates, with subgroup and meta-regression analyses. Thirteen studies comprising 5,766 participants were included. The pooled prevalence of PGD during the pandemic period was 24% (95% CI: 13%–36%), with the highest estimates observed in China (43%, 95% CI: 33%–54%). In the overall pooled analysis, studies applying DSM-5-TR criteria yielded lower prevalence estimates than those using ICD-11 criteria (18% vs.26%, p = 0.41). Digital interventions showed no statistically significant pooled effects (Hedges’ g = −0.38, 95% CI: −0.90 to 0.14). The high and geographically heterogeneous prevalence of PGD observed during the COVID-19 pandemic underscores the need to strengthen mental health surveillance, standardized assessment, and service accessibility in large-scale public health emergencies, and provides important evidence to inform population-level interventions and resource allocation strategies.
Estimating the prevalence of use of substances such as heroin remains a challenge. The aim of this study is to identify the scientific publications in Spain that have used surveys to investigate heroin use, to describe their methodology and to contrast the formulation of the questions with users’ input on key aspects associated with use.
Methods:
A scoping review was conducted until November 2024 in MEDLINE (Ovid), EMBASE and Web of Science. The review included questionnaire-based research studies assessing heroin use in Spain. Information on study, population, data collection and consumption characteristics was compiled from each included study. In addition, in-depth interviews were conducted with Spanish heroin current users and ex-users.
Results:
Twenty-nine questionnaire-based research studies assessing heroin use in Spain were identified; none of them were specifically oriented to estimate and characterise heroin use at the population level. Most of the studies focused on specific population groups, mainly drug users, students, or inmates. The majority addressed lifetime, past-year, and past-month use, although users found the past 3 or 6 months more relevant. Few studies explored other use characteristics; however, interviews with heroin ex-users highlighted the importance of factors like route of administration and age of first use.
Conclusions:
The studies identified in this review vary in terms of target population, geographic scope, reference time frame, and data collection methods. Moreover, questionnaires rarely address additional characteristics of use that are considered relevant by former users. This review identifies areas for improvement to guide future studies and refine methodological approaches.
To examine the association between dietary patterns and metabolic syndrome (MetS) in western China, which has not been previously reported.
Design:
A population based cross-sectional study design. Dietary intake was assessed using a semi-quantitative FFQ. Principal component analysis identified dietary patterns and multivariate logistic regression evaluated their associations with MetS.
Setting:
Population-based Cohort Study of Chronic Diseases in Xinjiang (PCCDX), conducted in 2022.
Participants:
A total of 3208 individuals from PCCDX (mean age: 53·1 (sd 10·8) years; 49·1 % male).
Results:
MetS was diagnosed in 1762 participants (54·9 %). Four distinct dietary patterns were identified, with the refined grain–animal products dietary pattern being the dominant one. After adjusting for general demographic and lifestyle factors, a higher score in the refined grain–animal product pattern was associated with an increased risk of MetS. The OR for the second, third and fourth quartiles of the dietary score were 1·07 (95 % CI: 0·860, 1·322), 1·14 (0·923, 1·413) and 1·48 (1·189, 1·853), with a statistically significant trend (P = 0·003). Higher dietary scores in this pattern were also associated with increased risks of elevated waist circumference, high TAG and low HDL cholesterol (P < 0·05). Mediation analysis showed that visceral fat percentage partially mediated the association between the refined grain–animal product dietary pattern and low HDL-cholesterol, accounting for 17·2 % of the total effect (indirect effect = 0·005, P = 0·006). The other three dietary patterns showed no significant associations with MetS or its components.
Conclusions:
This study highlights the high prevalence of MetS in western China and links a refined grains-animal products diet to poorer metabolic health, emphasising the need for region-specific dietary strategies.
Existing reviews on mental health disparities between deaf and hard‐of‐hearing (DHH) and hearing populations have focused predominantly on children, adolescents, or older adults, leaving a gap for working-age adults. We conducted a systematic review comparing the prevalence, incidence, and severity of any DSM-5-TR or ICD-11 mental disorder between DHH and hearing adults aged 18–60 years. We aimed to quantify disparities and examine disorder-specific patterns to inform future research, policy, and service development.
Methods
On 13 December 2025, we searched Ovid Medline, Embase, APA PsycINFO and Web of Science. We included analytical observational studies involving DHH and hearing adults aged 18–60 years, reporting mental disorder prevalence, incidence, or severity. Two researchers independently extracted data, and risk of bias (RoB) was assessed using the modified CLARITY tool. We narratively synthesised findings by aggregating outcomes at the study level using two approaches: summary and majority of the effect directions within a study. Subgroup syntheses examined outcome type, study RoB, age group and mental disorder category.
Results
Sixty studies (n = 8 578 466) met inclusion. In the summary-direction synthesis, 58.3% (35/60) of studies reported higher mental disorder outcomes for DHH adults, 21.7% (13/60) found no difference and 20.0% (12/60) had mixed findings; none indicated lower mental disorder outcomes for DHH. Under the majority-direction approach, 65.0% (39/60) showed higher mental disorder outcomes and 35.0% (21/60) no difference. These patterns were consistent across prevalence (62.8–72.1% higher) and severity (61.1% higher). Studies with higher RoB more often reported higher mental disorder outcomes (66.7–72.2%) than lower-RoB studies (54.8–61.9%), though both mirrored the overall synthesis. Effects were similar across younger (61.9–71.4%) and older adult samples (61.1–66.7% higher). Disorder-specific syntheses identified psychotic disorders, post-traumatic stress disorder and suicidal outcomes as having the strongest disparities (≥72.2% higher), followed by general mental disorders, anxiety and depression. Fewer than five studies examined each of the other disorders, thereby limiting conclusions for these disorders.
Conclusions
Most available evidence indicates that the prevalence and severity of mental disorders are higher among DHH adults aged 18–60 years than among hearing adults, with limited evidence on incidence. No studies reported lower aggregated mental disorder outcomes for DHH adults. Addressing these disparities requires targeted intervention research, supported by population-based, longitudinal and (quasi-)experimental studies including comprehensive reporting of participant characteristics. This will inform more tailored interventions, improve screening and ultimately contribute to better mental health and quality of life for DHH adults.
Domestic cats are the only felines living exclusively with humans, making them ecologically invasive and widespread across terrestrial habitats. Their domestication stems from their rodent control abilities and companionship. However, they are susceptible to gastrointestinal parasites such as Ancylostoma spp., Toxocara cati, and Dipylidium caninum, causing issues like anaemia, vomiting, and sometimes death, especially in kittens. These parasites can also pose zoonotic risks, transmitting diseases like visceral and ocular larva migrants to humans. A total of 100 cats with no deworming history were examined over six months. The overall prevalence of intestinal helminths was 23.0%, with Ancylostoma spp. being the most common (11.0%), followed by Toxocara cati (7.0%), Taenia spp. (2.0%), and mixed infections (3.0%). The prevalence was higher in females (26.92%) than in males (18.75%). Age-wise, kittens under 6 months had the highest infection rate (36.17%), while cats aged 6–12 months showed the lowest (10.71%). Non-descriptive breeds exhibited a higher infection rate (34.88%) than descriptive breeds (14.03%). Most cats were kept in confined spaces (72.0%), with 57.0% being descriptive breeds. Cats were mostly fed a mix of cooked and commercial cat food (59.0%), while only 33.0% were vaccinated and 20.0% dewormed. Behavioural issues like licking (51.0%) and self-biting (13.0%) were noted. Only 41.0% of owners were aware of zoonotic disease risks from cats. Chi-square analysis revealed significant associations between infection rates and risk factors (variables) such as breed, age, diet, vaccination, and deworming status. Non-descriptive breeds, unvaccinated cats, and those fed vegetarian diets had significantly higher infection rates (p < 0.05). Unconfined housing also contributed to increased infection risk, though not statistically significant. The research was significant because it highlighted the public health risks, as many cat owners and pet lovers were unaware of the zoonotic potential of intestinal helminths in cats.
Cytomegalovirus (CMV) is a ubiquitous virus with significant public health implications, including severe morbidity and mortality in neonates and immunosuppressed individuals. Substantial variation in CMV prevalence has been reported globally, and local epidemiological data are important to inform public health interventions. In this study, we estimated CMV seroprevalence and seroconversion rates among blood donors to provide baseline data on CMV epidemiology in Ireland. Seroprevalence was estimated in 74,821 donors, and seroconversion rates were calculated among returning donors, with associations assessed by demographic and geographical factors. Overall CMV seroprevalence in 2020 was 26.0% [95%CI: 25.7–26.3]. Female donors had higher odds of seropositivity than males (adjusted OR: 1.38, [95%CI: 1.34–1.43]). Among first-time donors, CMV seroprevalence was 23.82% [95% CI; 22.79–24.86], whereas within Sample Only New Donors (SOND), who are first-time donors born outside of Ireland and the UK, the seroprevalence was significantly higher, at 46.49% [95% CI; 40.41–52.98, p < 0.001]. The estimated annual seroconversion rate was 0.76% [95% CI: 0.68–0.85], with CMV DNA detected in 6.5% of seroconverters. These findings highlight a low CMV seroprevalence in Ireland, suggesting increased susceptibility to primary infection. Analysis of blood donor CMV data is a useful epidemiological tool to assess population-level risk.
Generalized anxiety disorder (GAD) is characterized by persistent worry and physical symptoms, with prevalence estimates ranging from 0.8% to 8%. Researchers utilize various tools, such as standardized diagnostic interviews and self-report questionnaires, to estimate GAD prevalence in population-level studies. However, the diagnostic accuracy of these tools varies greatly. This scoping review aimed to identify the tools used for GAD prevalence estimation and assess the extent to which diagnostic tool accuracy is reported.
Methods
A systematic search was conducted in MEDLINE, Embase and PsycINFO using MeSH terms and keywords related to GAD prevalence. No date restrictions were applied. Studies were eligible if they used nationally or regionally representative samples and defined GAD based on DSM-5, ICD-11 or older case definitions. Studies focusing solely on specific sub-groups were excluded. Data extraction included study characteristics, diagnostic tools and reporting of test accuracy.
Results
A total of 537 studies were initially identified, with 48 meeting inclusion criteria, published between 1994 and 2024. Most studies were conducted in Europe (43.75%) and employed cross-sectional designs (92%). Structured diagnostic interviews were the most commonly used tool (77.08%), although self-report questionnaires gained popularity after 2005. Among the included studies, 62.5% reported test accuracy, often addressing validity and reliability.
Conclusions
Despite the widespread use of diagnostic tools in prevalence studies, test accuracy is not consistently reported, which may impact the reliability of prevalence estimates. The variability in agreement between self-report questionnaires and structured diagnostic interviews highlights the need for transparent reporting of test characteristics to improve the validity of GAD prevalence assessments across populations.
Epidemiological evidence on the incidence and remission of anxiety and depressive disorders is limited. We estimated age- and sex-specific incidence and remission rates of moderate-to-severe anxiety and depressive symptoms using the illness-death model.
Methods
The German National Cohort (NAKO) is a cohort of over 200,000 participants aged 19–74 at baseline. Prevalence of probable cases, estimated with the Generalized Anxiety Disorder Scale and the Patient Health Questionnaire data 2014–2019 across five regions, was related to general mortality rates and disorder-specific mortality rate ratios in the illness-death model. The partial derivative of prevalence was modeled as a function of incidence and remission, with parameters estimated via least-squares optimization through 2,000 bootstrap resamples.
Results
The highest incidence rates (per 1,000 person-years) occurred at ages 19–21 for anxiety symptoms: 4.07 (95% CI: 0.00–7.57) in women and 2.55 (0.00–4.94) in men; and at ages 28–34 for depressive symptoms: 4.41 (0.00–9.81) in women and 3.30 (0.00–7.34) in men, all in Hamburg. Remission rates (per 100 person-years) were highest at older ages. For anxiety symptoms, rates peaked at 71.8 years in women (4.10 [0.00–11.94]) and 64.2 years in men (3.00 [0.00–9.23]) in Freiburg. For depressive symptoms, the highest observed was at 74.0 years, both among women (6.61 [0.00–15.50] in Münster) and men (3.58 [0.00–11.51] in Berlin).
Conclusions
Incidence and remission rates of anxiety and depressive symptoms can be estimated from prevalence and mortality data, revealing regional, sex-, and age-related variation. Validation with longitudinal data is warranted.
Professional burnout syndrome represents a significant occupational hazard within European primary care physicians, impacting their well-being, quality of care, and the sustainability of healthcare systems. This joint European Psychiatric Association (EPA) and the World Organization of National Colleges, Academies and Academic Associations of General Practitioners/Family Physicians- Europe Region (WONCA Europe) viewpoint focuses specifically on primary care physicians, contrasts their risk profile with other specialties, and outlines actionable, system-level recommendations for policymakers, provider organizations, and professional associations. Evidence indicates a wide range in professional burnout syndrome prevalence, influenced by assessment methodologies and specific national contexts. The syndrome manifests through emotional exhaustion, depersonalization, and reduced personal accomplishment, often accompanied by secondary psychological and physical symptoms. A multitude of interacting risk factors at the individual, interpersonal, and organizational levels contribute to its development. Effective mitigation strategies necessitate a multi-pronged approach encompassing individual coping mechanisms and systemic organizational changes aimed at alleviating workload, enhancing autonomy, and fostering supportive work environments.
Because of advances in technology and the provision of critical care, an increasing number of patients are surviving critical illness; this growing population of survivors of critical illness is characterized by heightened vulnerability to a host of adverse health outcomes and by the development of multidimensional impairments that significantly impact their quality of life and societal participation. Post-intensive care syndrome (PICS) is defined as new or worsening impairments in physical, cognitive, or mental health status arising after a critical illness and persisting beyond acute care hospitalization. PICS-Family describes the psychological and social impairments that family members, loved ones, and caregivers can develop as a consequence of their loved one’s critical illness. Survivors of critical illness are a heterogeneous patient population, and considerable variation exists with respect to the breadth, depth, duration, and mutability of their symptoms and impairments. This chapter explores the clinical manifestations of PICS, its incidence and prevalence, the co-occurrence of impairments in multiple domains, duration and severity of impairments, risk factors for its development, prediction tools, prevention strategies, screening and diagnosis, and treatment options. Additional topics include the biophysical model of disability, functional trajectories following critical illness, and the lack of communication about post-ICU problems.
This study focuses on the national and subnational estimation of prevalence, incidence, disability-adjusted life years (DALYs) related to self-harm and suicide mortality in Iran. These indicators of disease burden were analyzed over the period from 1990 to 2021, with stratifications based on sex, age and geographic location. Additionally, the percentage change observed between 1990 and 2021 was documented. The age-standardized prevalence rate (per 100,000) of self-harm decreased from 173.92 (95% UI: 146.13–208.75) in 1990 to 131.2 (95% UI: 110.55–156.67) in 2021, reflecting a percentage change of −0.25% over the period. In terms of self-harm prevalence in 2021, males had a higher rate (137.62 per 100,000) compared to females (124.82 per 100,000). The findings of the current study revealed that, despite significant challenges such as demographic shifts, economic instability and the impacts of war, the trends in self-harm incidents and suicide mortality rates in Iran have generally been on the decline. Additionally, it was observed that suicide-related deaths were more prevalent among males when compared to females. However, when examining self-harm behaviors over previous decades, these acts appeared to be more frequent among females.
Continuous traumatic stress (CTS) exposure describes extended and ongoing collective trauma exposure that is associated with potential future danger and threat to the community. CTS has generated debate in the context of current definitions of trauma and posttraumatic stress disorder (PTSD) in the DSM-5. Prevalence data on posttraumatic stress symptoms (PTSS) and PTSD in adolescents aged 10 to 24 years following CTS exposure in Sub-Saharan Africa are lacking. This systematic review and meta-analysis sought to address this gap. We also synthesized evidence on other trauma-related mental disorders and moderators such as mean age, sex, country income, education level, PTSS/PTSD assessment tool, and recruitment method. A systematic literature search covering four databases yielded 460 papers that were screened for eligibility, with 10 studies included. Data were extracted and coded, and a meta-analysis of the pooled prevalence of clinically significant PTSS/PTSD was conducted. Results indicated a pooled prevalence of PTSS/PTSD of 32.0% (95% CI: 20.7% to 46.0%). Country income (World Bank category) and type of assessment (clinician-administered vs. self-report) significantly moderated the prevalence of PTSS/PTSD. Further research is needed to not only measure CTS as an exposure but also as a response separate from PTSS/PTSD among adolescents in Sub-Saharan Africa. Additionally, research is needed to determine the validity, reliability, and cultural relevance of CTS response measures. Such studies will help in better understanding the psychosocial impact of CTS exposure on adolescents and inform the development of future interventions. Detailed data on the prevalence of PTSS/PTSD and moderators thereof following CTS exposure in Sub-Saharan Africa are sparse. Further studies are needed to characterize CTS-related comorbidities and related phenomena in adolescents living under conditions of CTS exposure and to optimize evidence-based interventions.
This systematic review and meta-analysis was a study that enquired into the prevalence and epidemiology of depression in university students in Pakistan, between 2000 and 2025. Depression is a significant global mental illness with high prevalence in young adulthood. University students are the most susceptible to this risk because of the factors related to it, i.e., academic stress, financial hardships, social pressure, and cultural stigma of mental illness. Although the concerns have been on the increase, the prevalence rates of depression have been widely varied among Pakistani students, with some studies reporting as low as 2.5% to as high as 85%, primarily because of the sampling techniques, assessment instruments, and geographical settings. The present review is based on the findings of 35 studies involving over 11,000 students and suggests that the prevalence rate is approximately 51% in a pooled form, meaning that about 50% of university students in Pakistan are subjected to depressive symptoms. The high level of heterogeneity of the selected studies highlights the acute necessity of the formulation of a standard-based diagnostic criteria and culturally competent mental health assessment instruments. Moreover, systemic challenges, such as the shortage of trained mental health professionals and the general unawareness of the disorder, are continuing to affect the diagnosis and treatment of the disorder at an early stage. According to the results, the necessity of a multi-faceted approach toward mental health, including the establishment of counseling facilities in universities, the development of stress management training, and the federal stigma-reduction campaign, is pressing. The most significant elements of enhancing the well-being of students and the mental health landscape of Pakistan as a whole are early intervention and empowering mental health infrastructure.
The heligmosomid nematodes Heligmosomum mixtum and Heligmosomoides glareoli are dominant helminths infecting bank voles (Clethrionomys glareolus) in the temperate forests of NE Poland. Both are relatively long-lived species that accumulate in hosts with increasing host age. Based on studies showing that the closely related species, Heligmosomoides bakeri is immunomodulatory in murine hosts, we hypothesized that heligmosomid-infected bank voles should show higher prevalence and abundance with other helminths. To test this hypothesis, we analysed a database containing quantitative data on helminth parasites of bank voles (n = 922), comprising worm burdens recorded during 4 surveys, conducted at 3- to 4-year intervals, in 3 forest sites, during late summer of each year. After controlling for both intrinsic and extrinsic factors, the presence of heligmosomid nematodes was significantly associated with higher species richness of other helminth species, with the greater likelihood of voles carrying other helminth species, with higher worm burdens of other helminths and with significant positive covariance of heligmosomid burdens with those of other concurrently residing helminths. These patterns might be explained by a number of biological processes, including correlated host exposure or correlated host susceptibility not driven by the parasitic infections themselves. However, we consider it most likely that these results are consistent with the idea that like H. bakeri, the heligmosomid nematodes of bank voles employ non-specific immunomodulation to facilitate their own long-term survival, with the consequence that other concurrently infecting intestinal helminths benefit.
This study aimed to assess the prevalence of post-COVID syndrome (PCS) and identify associated risk factors among healthcare workers (HCWs) in a large tertiary care hospital, with the objective of highlighting the importance of preparedness for similar post-viral syndromes in future pandemics.
Background:
Post-COVID syndrome, a form of post-viral syndrome, encompasses a range of long-term symptoms affecting multiple organ systems, which can persist after the recovery from COVID-19.
Methods:
A cross-sectional study was conducted using an online self-administered survey among HCWs who tested positive for COVID-19 at a large tertiary medical centre in Beirut.
Findings:
Among the 134 participants who had experienced COVID-19, nearly half (47.7%) reported symptoms consistent with PCS. Fatigue, shortness of breath, poor memory, and poor concentration were the most frequently reported symptoms, lasting for over three months post-COVID-19 infection in the majority of patients. Direct care of COVID-19 patients and higher severity of acute COVID-19 infection were significantly associated with an increased likelihood of developing PCS. Further research to enhance understanding and management of post-viral syndromes is needed. Additionally, proactive strategies should be implemented to mitigate associated risks in healthcare settings, emphasizing the importance of preparedness for future pandemics.
Accurate and up-to-date epidemiological data on the prevalence and treatment of common mental disorders are essential for evidence-based healthcare policy and resource allocation. However, large-scale, representative epidemiological surveys on common mental disorders in China—particularly those incorporating insomnia disorder and applying the latest diagnostic criteria alongside validated assessment tools—remain notably lacking.
Methods
We conducted a population-based, cross-sectional epidemiological survey to assess the prevalence and treatment of common mental disorders among adults in Beijing, China, using a multistage clustered probability sampling design (n = 10,778). Licensed psychiatrists administered standardized diagnostic interviews based on DSM-5 criteria to assess both lifetime and current mental disorders through a single-stage assessment protocol.
Results
Among all lifetime mental disorders assessed, depressive disorders constituted the most prevalent diagnostic category (7.7%), with major depressive disorder representing the most common specific diagnosis (5.4%). Individuals aged 65 years and older exhibited significantly higher 1-month prevalence of both depressive disorders and insomnia disorder compared with younger age groups. Alcohol-related disorder was more prevalent in men than in women, and in urban residents than in rural residents. Help-seeking patterns revealed a predominant reliance on informal support over professional services among individuals with lifetime mental disorders. Only 13.4% sought help from mental health professionals, and 12.7% received mental health professional treatment.
Conclusions
The improved access to treatment did not translate into a reduction in population-level mental disorder prevalence, which may be attributable to the low rate of professional mental health treatment. Governments must optimize mental healthcare access.